Back to top

Regeneron (REGN) Gets a Hold from Citi

In a report released yesterday, Geoff Meacham from Citi maintained a Hold rating on Regeneron, with a price target of $700.00. The company’s shares...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)